Fly News Breaks for June 22, 2018
CDNA, NTRA
Jun 22, 2018 | 08:46 EDT
Craig-Hallum analyst Alex Nowak reiterated a Buy rating on Natera (NTRA) after the company announced a new non-invasive kidney transplant rejection test. Natera will hold an investor call next Wednesday to discuss its plan in the transplantation and oncology markets, and Nowak thinks a distribution partnership could emerge on the call. Natera's news could be "headline negative" for competitors like CareDx (CDNA), Nowak says.
News For NTRA;CDNA From the Last 2 Days
There are no results for your query NTRA;CDNA